Skip to main content
Erschienen in: Tumor Biology 6/2014

01.06.2014 | Research Article

RETRACTED ARTICLE: The association of c.1471G>A genetic polymorphism in XRCC1 gene with lung cancer susceptibility in Chinese Han population

verfasst von: Li Wang, Zhenhong Chen, Yajuan Wang, De Chang, Longxiang Su, Yinghua Guo, Changting Liu

Erschienen in: Tumor Biology | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Lung cancer is one of the most spread cancers in the world. The X-ray repair cross-complementing group 1 (XRCC1) gene plays an important role in the development of lung cancer. The objective of this study is to investigate the potential association of XRCC1 genetic polymorphisms with the susceptibility to lung cancer. In totally, 361 lung cancer patients (male, 276; female, 85; mean age, 62.55) and 361 cancer-free controls (male, 253; female, 108; mean age, 61.33) were enrolled in this case–control study. The genotypes of XRCC1 c.1471G>A genetic polymorphism were determined by the created restriction site–polymerase chain reaction (CRS-PCR) and DNA sequencing methods. The influence of XRCC1 gene on the susceptibility to lung cancer was analyzed by the analyses association. Our data indicated that significant differences were found in the frequencies of allelic and genotypic between lung cancer patients and cancer-free controls. The c.1471G>A genetic polymorphism was statistically associated with increased susceptibility to lung cancer [AA vs. GG: odds ratio (OR) = 2.75, 95 % confidence interval (CI) = 1.55–4.88, P < 0.001; AA vs. GA/GG: OR = 2.69, 95 % CI = 1.55–4.69, P < 0.001; A vs. G: OR = 1.37, 95 % CI = 1.09–1.71, P = 0.007]. The allele A and genotype AA may contribute to the susceptibility to lung cancer. Taken together, these results showed that the functional c.1471G>A genetic polymorphism of XRCC1 was associated with lung cancer susceptibility in the studied population.
Literatur
1.
2.
3.
Zurück zum Zitat Guilbert JJ. The world health report 2002—reducing risks, promoting healthy life. Educ Health (Abingdon). 2003;16:230.CrossRef Guilbert JJ. The world health report 2002—reducing risks, promoting healthy life. Educ Health (Abingdon). 2003;16:230.CrossRef
4.
Zurück zum Zitat Yin Z, Zhou B, He Q, Li M, Guan P, Li X, et al. Association between polymorphisms in DNA repair genes and survival of non-smoking female patients with lung adenocarcinoma. BMC Cancer. 2009;9:439.CrossRefPubMedPubMedCentral Yin Z, Zhou B, He Q, Li M, Guan P, Li X, et al. Association between polymorphisms in DNA repair genes and survival of non-smoking female patients with lung adenocarcinoma. BMC Cancer. 2009;9:439.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Viktorsson K, De Petris L, Lewensohn R. The role of p53 in treatment responses of lung cancer. Biochem Biophys Res Commun. 2005;331:868–80.CrossRefPubMed Viktorsson K, De Petris L, Lewensohn R. The role of p53 in treatment responses of lung cancer. Biochem Biophys Res Commun. 2005;331:868–80.CrossRefPubMed
6.
Zurück zum Zitat Cui Z, Yin Z, Li X, Wu W, Guan P, Zhou B. Association between polymorphisms in XRCC1 gene and clinical outcomes of patients with lung cancer: a meta-analysis. BMC Cancer. 2012;12:71.CrossRefPubMedPubMedCentral Cui Z, Yin Z, Li X, Wu W, Guan P, Zhou B. Association between polymorphisms in XRCC1 gene and clinical outcomes of patients with lung cancer: a meta-analysis. BMC Cancer. 2012;12:71.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Qian B, Zhang H, Zhang L, Zhou X, Yu H, Chen K. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Lung Cancer. 2011;73:138–46.CrossRefPubMed Qian B, Zhang H, Zhang L, Zhou X, Yu H, Chen K. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Lung Cancer. 2011;73:138–46.CrossRefPubMed
8.
Zurück zum Zitat Sreeja L, Syamala VS, Syamala V, Hariharan S, Raveendran PB, Vijayalekshmi RV, et al. Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India. J Cancer Res Clin Oncol. 2008;134:645–52.CrossRefPubMed Sreeja L, Syamala VS, Syamala V, Hariharan S, Raveendran PB, Vijayalekshmi RV, et al. Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India. J Cancer Res Clin Oncol. 2008;134:645–52.CrossRefPubMed
9.
Zurück zum Zitat Lopez-Cima MF, Gonzalez-Arriaga P, Garcia-Castro L, Pascual T, Marron MG, Puente XS, et al. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain. BMC Cancer. 2007;7:162.CrossRefPubMed Lopez-Cima MF, Gonzalez-Arriaga P, Garcia-Castro L, Pascual T, Marron MG, Puente XS, et al. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain. BMC Cancer. 2007;7:162.CrossRefPubMed
10.
Zurück zum Zitat Giachino DF, Ghio P, Regazzoni S, Mandrile G, Novello S, Selvaggi G, et al. Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer. Clin Cancer Res. 2007;13:2876–81.CrossRefPubMed Giachino DF, Ghio P, Regazzoni S, Mandrile G, Novello S, Selvaggi G, et al. Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer. Clin Cancer Res. 2007;13:2876–81.CrossRefPubMed
11.
Zurück zum Zitat Chen J, Zhao QW, Shi GM, Wang LR. XRCC1 Arg399Gln and clinical outcome of platinum-based treatment for advanced non-small cell lung cancer: a meta-analysis in 17 studies. J Zhejiang Univ Sci B. 2012;13:875–83.CrossRefPubMedPubMedCentral Chen J, Zhao QW, Shi GM, Wang LR. XRCC1 Arg399Gln and clinical outcome of platinum-based treatment for advanced non-small cell lung cancer: a meta-analysis in 17 studies. J Zhejiang Univ Sci B. 2012;13:875–83.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Guo S, Li X, Gao M, Li Y, Song B, Niu W. The relationship between XRCC1 and XRCC3 gene polymorphisms and lung cancer risk in northeastern Chinese. PLoS One. 2013;8:e56213.CrossRefPubMedPubMedCentral Guo S, Li X, Gao M, Li Y, Song B, Niu W. The relationship between XRCC1 and XRCC3 gene polymorphisms and lung cancer risk in northeastern Chinese. PLoS One. 2013;8:e56213.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Hao B, Miao X, Li Y, Zhang X, Sun T, Liang G, et al. A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer. Oncogene. 2006;25:3613–20.CrossRefPubMed Hao B, Miao X, Li Y, Zhang X, Sun T, Liang G, et al. A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer. Oncogene. 2006;25:3613–20.CrossRefPubMed
14.
Zurück zum Zitat Yin J, Vogel U, Ma Y, Qi R, Wang H. Association of DNA repair gene XRCC1 and lung cancer susceptibility among nonsmoking Chinese women. Cancer Genet Cytogenet. 2009;188:26–31.CrossRefPubMed Yin J, Vogel U, Ma Y, Qi R, Wang H. Association of DNA repair gene XRCC1 and lung cancer susceptibility among nonsmoking Chinese women. Cancer Genet Cytogenet. 2009;188:26–31.CrossRefPubMed
15.
Zurück zum Zitat Kalikaki A, Kanaki M, Vassalou H, Souglakos J, Voutsina A, Georgoulias V, et al. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer. Clin Lung Cancer. 2009;10:118–23.CrossRefPubMed Kalikaki A, Kanaki M, Vassalou H, Souglakos J, Voutsina A, Georgoulias V, et al. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer. Clin Lung Cancer. 2009;10:118–23.CrossRefPubMed
16.
Zurück zum Zitat Chang JS, Wrensch MR, Hansen HM, Sison JD, Aldrich MC, Quesenberry Jr CP, et al. Base excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African-Americans. Carcinogenesis. 2009;30:78–87.CrossRefPubMed Chang JS, Wrensch MR, Hansen HM, Sison JD, Aldrich MC, Quesenberry Jr CP, et al. Base excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African-Americans. Carcinogenesis. 2009;30:78–87.CrossRefPubMed
17.
Zurück zum Zitat Butkiewicz D, Rusin M, Sikora B, Lach A, Chorazy M. An association between DNA repair gene polymorphisms and survival in patients with resected non-small cell lung cancer. Mol Biol Rep. 2011;38:5231–41.CrossRefPubMed Butkiewicz D, Rusin M, Sikora B, Lach A, Chorazy M. An association between DNA repair gene polymorphisms and survival in patients with resected non-small cell lung cancer. Mol Biol Rep. 2011;38:5231–41.CrossRefPubMed
18.
Zurück zum Zitat Li Y, Huang XE, Jin GF, Shen HB, Xu L. Lack of any relationship between chemotherapy toxicity in non-small cell lung cancer cases and polymorphisms in XRCC1 codon 399 or XPD codon 751. Asian Pac J Cancer Prev. 2011;12:739–42.PubMed Li Y, Huang XE, Jin GF, Shen HB, Xu L. Lack of any relationship between chemotherapy toxicity in non-small cell lung cancer cases and polymorphisms in XRCC1 codon 399 or XPD codon 751. Asian Pac J Cancer Prev. 2011;12:739–42.PubMed
19.
Zurück zum Zitat Wang Y, Yang H, Li H, Li L, Wang H, Liu C, et al. Association between X-ray repair cross complementing group 1 codon 399 and 194 polymorphisms and lung cancer risk: a meta-analysis. Cancer Lett. 2009;285:134–40.CrossRefPubMed Wang Y, Yang H, Li H, Li L, Wang H, Liu C, et al. Association between X-ray repair cross complementing group 1 codon 399 and 194 polymorphisms and lung cancer risk: a meta-analysis. Cancer Lett. 2009;285:134–40.CrossRefPubMed
20.
Zurück zum Zitat Karkucak M, Yakut T, Evrensel T, Deligonul A, Gulten T, Ocakoglu G, et al. XRCC1 gene polymorphisms and risk of lung cancer in Turkish patients. Int J Hum Genet. 2012;2:113–7. Karkucak M, Yakut T, Evrensel T, Deligonul A, Gulten T, Ocakoglu G, et al. XRCC1 gene polymorphisms and risk of lung cancer in Turkish patients. Int J Hum Genet. 2012;2:113–7.
21.
Zurück zum Zitat Huang G, Cai S, Wang W, Zhang Q, Liu A. Association between XRCC1 and XRCC3 polymorphisms with lung cancer risk: a meta-analysis from case-control studies. PLoS One. 2013;8:e68457.CrossRefPubMedPubMedCentral Huang G, Cai S, Wang W, Zhang Q, Liu A. Association between XRCC1 and XRCC3 polymorphisms with lung cancer risk: a meta-analysis from case-control studies. PLoS One. 2013;8:e68457.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Letkova L, Matakova T, Musak L, Sarlinova M, Krutakova M, Slovakova P, et al. DNA repair genes polymorphism and lung cancer risk with the emphasis to sex differences. Mol Biol Rep. 2013;40:5261–73.CrossRefPubMed Letkova L, Matakova T, Musak L, Sarlinova M, Krutakova M, Slovakova P, et al. DNA repair genes polymorphism and lung cancer risk with the emphasis to sex differences. Mol Biol Rep. 2013;40:5261–73.CrossRefPubMed
23.
Zurück zum Zitat Li Y, Huang Y, Cao YS, Zeng J, Tong WN, Xu SL, et al. Assessment of the association between XRCC1 Arg399Gln polymorphism and lung cancer in Chinese. Tumour Biol. 2013;34:3681–5.CrossRefPubMed Li Y, Huang Y, Cao YS, Zeng J, Tong WN, Xu SL, et al. Assessment of the association between XRCC1 Arg399Gln polymorphism and lung cancer in Chinese. Tumour Biol. 2013;34:3681–5.CrossRefPubMed
25.
Zurück zum Zitat Rybarova S, Hodorova I, Muri J, Mihalik J, Adamkov M, Svajdler M, et al. Prognostic significance of p53 protein and X-ray repair cross-complementing protein 1 in non-small cell lung cancer. Tumori. 2011;97:79–85.PubMed Rybarova S, Hodorova I, Muri J, Mihalik J, Adamkov M, Svajdler M, et al. Prognostic significance of p53 protein and X-ray repair cross-complementing protein 1 in non-small cell lung cancer. Tumori. 2011;97:79–85.PubMed
26.
Zurück zum Zitat Perez-Morales R, Mendez-Ramirez I, Castro-Hernandez C, Martinez-Ramirez OC, Gonsebatt ME, Rubio J. Polymorphisms associated with the risk of lung cancer in a healthy Mexican Mestizo population: application of the additive model for cancer. Genet Mol Biol. 2011;34:546–52.CrossRefPubMedPubMedCentral Perez-Morales R, Mendez-Ramirez I, Castro-Hernandez C, Martinez-Ramirez OC, Gonsebatt ME, Rubio J. Polymorphisms associated with the risk of lung cancer in a healthy Mexican Mestizo population: application of the additive model for cancer. Genet Mol Biol. 2011;34:546–52.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Natukula K, Jamil K, Pingali UR, Attili VS, Madireddy UR. The codon 399 Arg/Gln XRCC1 polymorphism is associated with lung cancer in Indians. Asian Pac J Cancer Prev. 2013;14:5275–9.CrossRefPubMed Natukula K, Jamil K, Pingali UR, Attili VS, Madireddy UR. The codon 399 Arg/Gln XRCC1 polymorphism is associated with lung cancer in Indians. Asian Pac J Cancer Prev. 2013;14:5275–9.CrossRefPubMed
28.
Zurück zum Zitat Sun Y, Zhang YJ, Kong XM. No association of XRCC1 and CLPTM1L polymorphisms with non-small cell lung cancer in a non-smoking Han Chinese population. Asian Pac J Cancer Prev. 2013;14:5171–4.CrossRefPubMed Sun Y, Zhang YJ, Kong XM. No association of XRCC1 and CLPTM1L polymorphisms with non-small cell lung cancer in a non-smoking Han Chinese population. Asian Pac J Cancer Prev. 2013;14:5171–4.CrossRefPubMed
29.
Zurück zum Zitat Guo QX, Yang WH, Zhai JF, Han FC, Wang CY. XRCC1 codon 280 polymorphism and susceptibility to lung cancer: a meta-analysis of the literatures. Tumour Biol. 2013;34:2989–94.CrossRefPubMed Guo QX, Yang WH, Zhai JF, Han FC, Wang CY. XRCC1 codon 280 polymorphism and susceptibility to lung cancer: a meta-analysis of the literatures. Tumour Biol. 2013;34:2989–94.CrossRefPubMed
30.
Zurück zum Zitat Ouyang FD, Yang FL, Chen HC, Khan MA, Huang FM, Wan XX, et al. Polymorphisms of DNA repair genes XPD, XRCC1, and OGG1, and lung adenocarcinoma susceptibility in Chinese population. Tumour Biol. 2013;34:2843–8.CrossRefPubMed Ouyang FD, Yang FL, Chen HC, Khan MA, Huang FM, Wan XX, et al. Polymorphisms of DNA repair genes XPD, XRCC1, and OGG1, and lung adenocarcinoma susceptibility in Chinese population. Tumour Biol. 2013;34:2843–8.CrossRefPubMed
31.
Zurück zum Zitat Wang JY, Cai Y. X-ray repair cross-complementing group 1 codon 399 polymorphism and lung cancer risk: an updated meta-analysis. Tumour Biol. 2014;35:411–8.CrossRefPubMed Wang JY, Cai Y. X-ray repair cross-complementing group 1 codon 399 polymorphism and lung cancer risk: an updated meta-analysis. Tumour Biol. 2014;35:411–8.CrossRefPubMed
32.
Zurück zum Zitat Wu T, Xu YH, Ye XL. X-ray repair cross-complementing group 1 Arg194Trp polymorphism is associated with increased risk of lung cancer in Chinese Han population. Tumour Biol. 2013;34:2611–5.CrossRefPubMed Wu T, Xu YH, Ye XL. X-ray repair cross-complementing group 1 Arg194Trp polymorphism is associated with increased risk of lung cancer in Chinese Han population. Tumour Biol. 2013;34:2611–5.CrossRefPubMed
33.
Zurück zum Zitat Li D, Zhou Q, Liu Y, Yang Y, Li Q. DNA repair gene polymorphism associated with sensitivity of lung cancer to therapy. Med Oncol. 2012;29:1622–8.CrossRefPubMed Li D, Zhou Q, Liu Y, Yang Y, Li Q. DNA repair gene polymorphism associated with sensitivity of lung cancer to therapy. Med Oncol. 2012;29:1622–8.CrossRefPubMed
34.
Zurück zum Zitat Ke HG, Li J, Shen Y, You QS, Yan Y, Dong HX, et al. Prognostic significance of GSTP1, XRCC1 and XRCC3 polymorphisms in non-small cell lung cancer patients. Asian Pac J Cancer Prev. 2012;13:4413–6.CrossRefPubMed Ke HG, Li J, Shen Y, You QS, Yan Y, Dong HX, et al. Prognostic significance of GSTP1, XRCC1 and XRCC3 polymorphisms in non-small cell lung cancer patients. Asian Pac J Cancer Prev. 2012;13:4413–6.CrossRefPubMed
35.
Zurück zum Zitat Dai L, Duan F, Wang P, Song C, Wang K, Zhang J. XRCC1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case-control studies. Mol Biol Rep. 2012;39:9535–47.CrossRefPubMed Dai L, Duan F, Wang P, Song C, Wang K, Zhang J. XRCC1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case-control studies. Mol Biol Rep. 2012;39:9535–47.CrossRefPubMed
36.
Zurück zum Zitat Huang J, Zhang J, Zhao Y, Liao B, Liu J, Li L, et al. The Arg194Trp polymorphism in the XRCC1 gene and cancer risk in Chinese Mainland population: a meta-analysis. Mol Biol Rep. 2011;38:4565–73.CrossRefPubMed Huang J, Zhang J, Zhao Y, Liao B, Liu J, Li L, et al. The Arg194Trp polymorphism in the XRCC1 gene and cancer risk in Chinese Mainland population: a meta-analysis. Mol Biol Rep. 2011;38:4565–73.CrossRefPubMed
37.
Zurück zum Zitat Haliassos A, Chomel JC, Tesson L, Baudis M, Kruh J, Kaplan JC, et al. Modification of enzymatically amplified DNA for the detection of point mutations. Nucleic Acids Res. 1989;17:3606.CrossRefPubMedPubMedCentral Haliassos A, Chomel JC, Tesson L, Baudis M, Kruh J, Kaplan JC, et al. Modification of enzymatically amplified DNA for the detection of point mutations. Nucleic Acids Res. 1989;17:3606.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Yuan ZR, Li J, Li JY, Gao X, Xu SZ. SNPs identification and its correlation analysis with milk somatic cell score in bovine MBL1 gene. Mol Biol Rep. 2013;40:7–12.CrossRefPubMed Yuan ZR, Li J, Li JY, Gao X, Xu SZ. SNPs identification and its correlation analysis with milk somatic cell score in bovine MBL1 gene. Mol Biol Rep. 2013;40:7–12.CrossRefPubMed
39.
Zurück zum Zitat Yuan ZR, Li JY, Li J, Zhang LP, Gao X, Gao HJ, et al. Investigation on BRCA1 SNPs and its effects on mastitis in Chinese commercial cattle. Gene. 2012;505:190–4.CrossRefPubMed Yuan ZR, Li JY, Li J, Zhang LP, Gao X, Gao HJ, et al. Investigation on BRCA1 SNPs and its effects on mastitis in Chinese commercial cattle. Gene. 2012;505:190–4.CrossRefPubMed
40.
Zurück zum Zitat Yuan ZR, Li JY, Li J, Gao X, Xu SZ. Effects of DGAT1 gene on meat and carcass fatness quality in Chinese commercial cattle. Mol Biol Rep. 2013;40:1947–54.CrossRefPubMed Yuan ZR, Li JY, Li J, Gao X, Xu SZ. Effects of DGAT1 gene on meat and carcass fatness quality in Chinese commercial cattle. Mol Biol Rep. 2013;40:1947–54.CrossRefPubMed
41.
Zurück zum Zitat Zhao CJ, Li N, Deng XM. The establishment of method for identifying SNP genotype by CRS-PCR. Yi Chuan. 2003;25:327–9.PubMed Zhao CJ, Li N, Deng XM. The establishment of method for identifying SNP genotype by CRS-PCR. Yi Chuan. 2003;25:327–9.PubMed
Metadaten
Titel
RETRACTED ARTICLE: The association of c.1471G>A genetic polymorphism in XRCC1 gene with lung cancer susceptibility in Chinese Han population
verfasst von
Li Wang
Zhenhong Chen
Yajuan Wang
De Chang
Longxiang Su
Yinghua Guo
Changting Liu
Publikationsdatum
01.06.2014
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 6/2014
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-1702-x

Weitere Artikel der Ausgabe 6/2014

Tumor Biology 6/2014 Zur Ausgabe

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Alter verschlechtert Prognose bei Endometriumkarzinom

11.05.2024 Endometriumkarzinom Nachrichten

Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.